Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIG1 hypoxia inducible domain family member 1A pseudogene (HIGD1AP) is a pseudogene in the human genome that does not encode a functional protein. Pseudogenes like HIGD1AP are typically regarded as non-coding genomic elements that have lost their protein-coding ability due to mutations, deletions, or insertions. Some human pseudogenes transcribe RNA that may play a regulatory role, such as acting as competitive endogenous RNAs or influencing expression of related protein-coding genes. However, there is currently no evidence that HIGD1AP functions as a therapeutic target, nor is it associated with any direct disease phenotypes or druggable mechanisms. It is categorized as a processed pseudogene within the HIG1 hypoxia inducible domain family. For research and clinical purposes, it should not be considered a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIG1 hypoxia inducible domain family member 1A pseudogene (HIGD1AP).